Neural tube defects and integrase inhibitors: still waiting for stronger evidence
Two new types of cell therapy could target reservoir cells and permanently stop HIV infection
Do integrase inhibitors raise the risk of obesity?
Benefits of dolutegravir treatment for all substantially outweigh the risks
Fostemsavir, novel gp120 inhibitor, salvages nearly half of people with no other treatment options left
Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows
First large HIV prevention trial using antibodies will probably not be the last
The Miami monkey cured with two antibodies
Studies confirm long-term effectiveness of new single-tablet regimens
